134
Views
0
CrossRef citations to date
0
Altmetric
Infection

308-nm excimer laser: a hopeful and optional therapy for pityriasis versicolor

ORCID Icon &
Pages 795-799 | Received 26 Oct 2019, Accepted 01 Jan 2020, Published online: 06 Mar 2020

References

  • Gupta AK, Batra R, Bluhm R, et al. Pityriasis versicolor. Dermatol Clin. 2003;21:413–429.
  • Cam VT, Van TN, Hau KT, et al. Efficacy of azole antifungal in treatment of pityriasis versicolor. Open Access Macedonian J Med Sci. 2019;7:272–274.
  • Blessmann WM, Sponchiado de Avila LG, Albaneze R, et al. Pityriasis alba: a study of pathogenic factors. J Eur Acad Dermatol Venerol. 2002;16:463–468.
  • Cam VT, Van TN, Hau KT, et al. Distribution of Malassezia species from scales of patient with pityriasis versicolor by culture in Vietnam. Open Access Macedonian J Med Sci. 2019;7:184–186.
  • Renati S, Cukras A, Bigby M. Pityriasis versicolor. BMJ. 2015;350:h1394
  • Kallini JR, Riaz F, Khachemoune A. Tinea versicolor in dark-skinned individuals. Int J Dermatol. 2014;53:137–141.
  • Wikler JR, Janssen N, Bruynzeel DP, et al. The effect of UV-light on pityrosporum yeasts: ultrastructural changes and inhibition of growth. Acta Derm Venereol. 1990;70:69–71.
  • Aljabre SH, Alzayir AA, Abdulghani M, et al. Pigmentarychanges of tinea versicolor in dark-skinned patients. Int J Dermatol. 2001;40:273–275.
  • Khattab FM, Abdelbary E, Fawzi M. Evaluation of combined excimer laser and platelet-rich plasma for the treatment of nonsegmental vitiligo: A prospective comparative study. J Cosmet Dermatol.. 2019. DOI: https://doi.org/10.1111/jocd.13103. [Epub ahead of print].
  • Friedman PM, Geronemus RG. Use of the 308-nm excimer laser for postresurfacing leukoderma. Arch Dermatol. 2001;137:824–825.
  • Passeron T, Zakaria W, Ostovari N, et al. Efficacy of the 308-nm excimer laser in the treatment of mycosis fungoides. Arch Dermatol. 2004;140:1291–1293.
  • Kollner K, Wimmershoff M, Landthaler M, et al. Treatment of oral lichen planus with the 308-nm UVB excimer laser. Early preliminary results in eight patients. Lasers Surg Med. 2003;33:158–160.
  • Baltas E, Csoma Z, Bodai L, et al. Treatment of atopic dermatitis with the xenon chloride excimer laser. J Eur Acad Dermatol Venerol. 2006;20:657–660.
  • Al-Mutairi N. 308-nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol. 2009;26:547–550.
  • Topaz O. Excimer laser – The Great Plaque Modifier. Cardiovasc Revasc Med. 2019;20:271–272.
  • Alexiades-Armenakas MR, Bernstein LJ, Friedman PM, et al. The safety and efficacy of the 308-nm excimer laser for pigment correction of hypopigmented scars and striae alba. Arch Dermatol. 2004;140:955–960.
  • Spencer JM, Nossa RA, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol. 2002;46:727–731.
  • Pirkhammer D, Seeber A, Hönigsmann H, et al. Narrow-band € ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol. 2000;143:964–968.
  • Balevi A, Üstüner P, Kakşi SA, et al. Narrow-band UV-B phototherapy: an effective and reliable treatment alternative for extensive and recurrent pityriasis versicolor. J Dermatolog Treat. 2018;29:252–255.
  • Ravanat JL, Douki T, Cadet J. Direct and indirect effects of UV radiation on DNA and its components. J Photochem Photobiol B. 2001;63:88–102.
  • Schwarz T. The dark and the sunny sides of UVR-induced immunosuppression: photoimmunology revisited. J Invest Dermatol. 2010;130:49–54.
  • Juzeniene A, Grigalavicius M, Juraleviciute M, et al. Phototherapy and vitamin D. Clin Dermatol. 2016;34:548–555.
  • Mayser P, Schafer U, Kramer HJ, et al. Pityriacitrin – an ultraviolet-absorbing indole alkaloid from the yeast Malassezia furfur. Arch Dermatol Res. 2002;294:131–134.
  • Gupta AK, Bluhm R, Summerbell R. Pityriasis versicolor. J Eur Acad Dermatol Venerol. 2002;16:19–33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.